Novo Nordisk Partners with WeightWatchers to Distribute Wegovy
Novo Nordisk announces a strategic collaboration with WeightWatchers for the distribution of Wegovy, a leading weight-loss medication, effective July 1. This partnership marks a significant step in making Wegovy more accessible to those seeking effective weight management solutions. Stay informed about the latest developments in health and wellness with Reuters.
Sign in to join the conversation.
Sign in with Google
Comments